Výsledky vyhledávání - "Alan H. Heaton"

Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated With Five Risk-Warning Events

Autor: Patrick P. Gleason, Jeremy A. Schafer, Catherine I. Starner, Alan H. Heaton

Publikováno v: Journal of Managed Care Pharmacy. 14:523-531

Rosiglitazone was approved by the U.S. Food and Drug Administration (FDA) for type 2 diabetes in 1999. The unique mechanism of action and low risk of hypoglycemia contributed to rapid market uptake of rosiglitazone, but safety concerns became more pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7458b10f42ba07e6a4d8369b39dcfea3
https://doi.org/10.18553/jmcp.2008.14.6.523

Zobrazit plný text záznamu

Relationship of the Magnitude of Member Cost-Share and Medication Persistence With Newly Initiated Renin Angiotensin System Blockers

Autor: Dongmu Zhang, Jon C. Schommer, Stephen W. Schondelmeyer, Patrick P. Gleason, Angeline M. Carlson, Alan H. Heaton, Bryan E Dowd

Publikováno v: Journal of Managed Care Pharmacy. 13:664-676

Effective treatment for chronic diseases often requires medication refill persistence. Health plans have frequently increased the amount of member cost-sharing by implementing tier-copayment pharmacy benefit designs and raising copayments. However, i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb400913081927853c670a8c9a4687db
https://doi.org/10.18553/jmcp.2007.13.8.664

Zobrazit plný text záznamu

The Influence of the Structure and Culture of Medical Group Practices on Prescription Drug Errors

Autor: Alan H. Heaton, John E. Kralewski, Bryan E Dowd, Amer A Kaissi

Publikováno v: Medical Care. 43:817-825

Background: This project was designed to identify the magnitude of prescription drug errors in medical group practices and to explore the influence of the practice structure and culture on those error rates. Seventy-eightpractices serving an upper Mi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaccdede664ee70a5e59771276d4d677
https://doi.org/10.1097/01.mlr.0000170419.70346.b8

Zobrazit plný text záznamu

High Frequency of Itraconazole Prescriptions with Potentially Interacting Medications in a Large Health Care Plan

Autor: Alan H. Heaton

Publikováno v: Journal of Managed Care Pharmacy. 8:199-203

OBJECTIVE: The objective of this study was to determine the frequency with which potentially interacting medications are prescribed. Patients in a large Midwestern U.S. managed care health plan who received prescriptions for itraconazole, an antifung

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::245dea1c7966a854095156e58b73858d
https://doi.org/10.18553/jmcp.2002.8.3.199

Zobrazit plný text záznamu

Public Health, Managed Care, and Pharmacy: An Evolving Trifecta

Autor: Alan H. Heaton

Publikováno v: Journal of Managed Care Pharmacy. 7:12-16

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fc48ed4311abaff951ae69a9f4442be5
https://doi.org/10.18553/jmcp.2001.7.1.12

Zobrazit plný text záznamu

The DERP: Is It An Effective Methodology?

Autor: Alan H. Heaton

Publikováno v: Health Affairs. 25:W276-W278

The Drug Effectiveness Review Project (DERP) is a process with challenges as well as rewards. This Perspective explores the issues that hamper the DERP's effectiveness and discusses the c...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fbe5138858e8c1672821fac7ac049db5
https://doi.org/10.1377/hlthaff.25.w276

Zobrazit plný text záznamu

Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit

Autor: Holly A, Rodin, Alan H, Heaton, Amy R, Wilson, Nancy A, Garrett, David W, Plocher

Publikováno v: The American journal of managed care. 15(12)

To evaluate the effect on adherence and medical care expenditures of a pharmacy benefit change that included free generic drugs and higher copayments for brand-name drugs.Quasi-experimental pre-post study of patients with ischemic heart disease (1286

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b71078353428399e1bf004420d83bde3
https://pubmed.ncbi.nlm.nih.gov/20001169

Zobrazit plný text záznamu

An Evaluation of the Relationship Between the Implementation of a Newly Designed Prescription Drug Label at Target Pharmacies and Health Outcomes

Autor: Alan H. Heaton, Carol Walters, Niteesh K. Choudhry, Sebastian Schneeweiss, Jerry Avorn, Claire Canning, Saira Jan, Amanda R. Patrick, Patrick P. Gleason, Daniel H. Solomon, Michael S. Wolf, M. Alan Brookhart, William H. Shrank

Medication errors represent a major public health concern, and inadequate prescription drug labels have been identified as a root cause of errors. A new prescription medication labeling system was implemented by Target pharmacies in May 2005 and aime

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::376f5ca177165c2d1e5bc7f0482d5684
https://europepmc.org/articles/PMC2873616/

Zobrazit plný text záznamu

Clinical and economic outcomes of medication therapy management services: the Minnesota experience

Autor: Alan H. Heaton, Lawrence M. Brown, Margaret B. Artz, Robert J. Cipolle, Brian J. Isetts, Lois A. Lenarz, Stephen W. Schondelmeyer, Wallace B. Wadd

Publikováno v: Journal of the American Pharmacists Association : JAPhA. 48(2)

To (1) provide medication therapy management (MTM) services to patients, (2) measure the clinical effects associated with the provision of MTM services, (3) measure the percent of patients achieving Healthcare Effectiveness Data and Information Set (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d41357f064e857bcd945d7c6318b96e6
https://pubmed.ncbi.nlm.nih.gov/18359733

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání